SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001425
Filing Date
2024-08-14
Accepted
2024-08-14 14:50:51
Documents
65
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eyen-20240630x10q.htm   iXBRL 10-Q 1418358
2 EX-31.1 eyen-20240630xex31d1.htm EX-31.1 14131
3 EX-31.2 eyen-20240630xex31d2.htm EX-31.2 14186
4 EX-32.1 eyen-20240630xex32d1.htm EX-32.1 8221
5 EX-32.2 eyen-20240630xex32d2.htm EX-32.2 7410
  Complete submission text file 0001410578-24-001425.txt   6704041

Data Files

Seq Description Document Type Size
6 EX-101.SCH eyen-20240630.xsd EX-101.SCH 58532
7 EX-101.CAL eyen-20240630_cal.xml EX-101.CAL 57060
8 EX-101.DEF eyen-20240630_def.xml EX-101.DEF 171908
9 EX-101.LAB eyen-20240630_lab.xml EX-101.LAB 403050
10 EX-101.PRE eyen-20240630_pre.xml EX-101.PRE 331794
68 EXTRACTED XBRL INSTANCE DOCUMENT eyen-20240630x10q_htm.xml XML 1200521
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38365 | Film No.: 241206649
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)